Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 22 - Number 13

Biography   Open Access


Review Article (Mini-Review)

Anti-inflammatory Potential of GSK-3 Inhibitors

, 22(13): 1464 - 1476

Chandi C. Kandar, Debanjan Sen and Arindam Maity*


DOI: 10.2174/1389450122666210118150313



Review Article

Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis

, 22(13): 1477 - 1484

Jyotika Rajawat* and Abhishek Chandra*


DOI: 10.2174/1389450122666210120142746



Review Article

GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma

, 22(13): 1485 - 1495

Sitansu S. Nanda, Md Imran Hossain, Heongkyu Ju and Dong Kee Yi*


DOI: 10.2174/1389450122666210204203950



Review Article

Review of the Biological Activity of Maslinic Acid

, 22(13): 1496 - 1506

Zhang Jing, Wang Rui, Li Ruihua, Yu Hao* and Fang Hengtong*


DOI: 10.2174/1389450122666210308111159



Review Article

Recent Advancement in Topical Drug Delivery for Psoriasis: Clinical Pertinence and Potential Market

, 22(13): 1507 - 1523

Rakhi Kumari, Jitu Halder, Amit Sharma and Vineet Kumar Rai*


DOI: 10.2174/1389450122666210412124256



Review Article

The Role of Non-coding Genome in Cancer-associated Fibroblasts; Stateof- the-Art and Perspectives in Cancer Targeted Therapy

, 22(13): 1524 - 1535

Arezoo G. Shabgah, Hamed Mohammadi, Pouya Goleij, Mahdiyeh Hedayati-Moghadam, Arash Salmaninejad and Jamshid G. Navashenaq*


DOI: 10.2174/1389450122666210216091953



Review Article

Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19

, 22(13): 1536 - 1547

Amritpal Kaur, Gaurav Chaudhary, Pargat Singh, Sandeep Arora and Rajwinder Kaur*


DOI: 10.2174/1389450121999201228212842



Review Article

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treating Breast and Ovarian Cancer

, 22(13): 1548 - 1554

Phool Chandra*, Neetu Sachan and Dilipkumar Pal


DOI: 10.2174/1389450122666210203183351



Review Article

GSK-3 Inhibitors as New Leads to Treat Type-II Diabetes

, 22(13): 1555 - 1567

Gowru Srivani, Ramyakrishna Sharvirala, Prabhakar Reddy Veerareddy, Dilipkumar Pal and Gangarapu Kiran*


DOI: 10.2174/1389450122666210120144428



Review Article

Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure

, 22(13): 1568 - 1576

Ubaid Tariq, Shravan K. Uppulapu and Sanjay K. Banerjee*


DOI: 10.2174/1389450122666210224105430




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Advertisement

Dec-2021-ban

Related Journals

Related eBooks

eBooks Catalog